此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

O2 Versus CPAP Treatment Of Patients Undergoing SIPE Therapy (OCTOPUS) (OCTOPUS)

2026年9月30日 更新者:Maria Hårdstedt、Dalarna County Council, Sweden

持续气道正压通气 (CPAP) 在游泳引起的肺水肿 (SIPE) 中的评估 - 一项随机单盲对照研究

In swimming induced pulmonary edema (SIPE), there is a lack of knowledge regarding optimal treatment. The present study was designed to assess the benefit of continuous positive airway pressure (CPAP) compared to oxygen as a first line treatment of SIPE in the out-of-hospital environment.

研究概览

详细说明

Swimming induced pulmonary edema (SIPE) is an unusual condition affecting otherwise healthy swimmers. SIPE is characterized by acute onset of dyspnea and cough, excessive sputum and occasionally hemoptysis when swimming in open water. The condition usually resolves spontaneously within 48 hours, but may result in serious illness and require emergency care. Case reports describe acute treatment with oxygen alone or in combination with diuretics, beta-agonist-inhalation or continuous positive airway pressure (CPAP). Evidence for optimal treatment strategy is lacking. This study intends to determine whether oxygen alone or applied together with CPAP leads to improvement of oxygen saturation and recovery of patients. The aim is to treat patients on site without involving hospital care. We study a large cohort of approximately 12 000 swimmers during Vansbrosimningen, Sweden's biggest annual open water event with a yearly incidence of SIPE about 0,4%.

Adult patients clinically diagnosed with SIPE are randomly assigned in 2 groups receiving treatment during 20 minutes: (1) oxygen 10l/min or (2) oxygen 10l/min and CPAP 7,5 cm H2O. Assessment with outcome measures is taken 10 minutes after treatment. Primary endpoint: oxygen saturation (%) by pulse oxymetry.

研究类型

介入性

注册 (估计的)

90

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

      • Falun、瑞典、79182
        • 招聘中
        • Center of Clinical Research Dalarna

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • clinical diagnosis of swimming induced pulmonary edema (SIPE) with need of acute treatment (oxygen saturation ≤91%)
  • 18 years and older
  • informed consent

Exclusion Criteria:

  • declined consent
  • suspected acute coronary syndrome
  • severe asthma diagnosed together with pulmonary edema where beta-agonist-inhalation is needed prior to treatment of pulmonary edema
  • hemodynamic instability or decreased consciousness

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:氧气 + CPAP 治疗

Oxygen-driven CPAP (7,5 cmH2O): 20 min treatment followed by 10 min rest and assessment

有源比较器:氧疗

Oxygen: 20 min treatment followed by 10 min rest and assessment

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Absolute peripheral oxygen saturation (%) after treatment
大体时间:after 20 min treatment followed by 10 min rest

Peripheral oxygen saturation % (continuous variable) measured by peripheral pulse oximetry

after 20 min treatment followed by 10 min rest

次要结果测量

结果测量
措施说明
大体时间
Change in absolute peripheral oxygen saturation (%) before and after treatment
大体时间:change before versus after 20 min treatment followed by 10 min rest

Change in peripheral oxygen saturation % (continuous variable) measured by pulse oximetry before and after treatment

change before versus after 20 min treatment followed by 10 min rest
Recovery (yes/no) after treatment
大体时间:after 20 min treatment followed by 10 min rest

Recovery, defined by "peripheral oxygen saturation >95% after treatment" or no recovery, defined by "peripheral oxygen saturation ≤95% after treatment"

after 20 min treatment followed by 10 min rest
Absolute number of regions presenting B-lines on lung ultrasound after treatment
大体时间:after 20 min treatment followed by 10 min rest

Four chest regions for both lungs are scanned by lung ultrasound; a positive region defined by the presence of three or more B-line artifacts. Assessment of the total number of positive regions.

after 20 min treatment followed by 10 min rest
Change in absolute number of regions presenting B-lines on lung ultrasound before and after treatment
大体时间:change before versus after 20 min treatment followed by 10 min rest

Four chest regions for both lungs are scanned by lung ultrasound; a positive region defined by the presence of three or more B-line artifacts. Assessment of the total number of positive regions. Change in absolute number of regions presenting B-lines on lung ultrasound before and after treatment

change before versus after 20 min treatment followed by 10 min rest
Interstitial syndrome assessed by lung ultrasound (yes/no) after treatment
大体时间:after 20 min treatment followed by 10 min rest

Four chest regions for both lungs are scanned by lung ultrasound; a positive region defined by the presence of three or more B-line artifacts. Bilateral or unilateral presence of two or more positive regions define positive interstitial syndrome.

after 20 min treatment followed by 10 min rest
Change in patient reported outcome measures before and after treatment
大体时间:change before versus after 20 min treatment followed by 10 min rest

Six different patient reported outcome measures assessed by numeric rating scale (NRS) 0-10: cough, sputum, air hunger, breathing effort, tightness in chest, anxiousness. The patients will assess symptoms prior to and after treatment.

change before versus after 20 min treatment followed by 10 min rest
Admission to hospital (yes/no)
大体时间:2 hours

admission to hospital within or after a maximal treatment time of 40 minutes followed by 20 min rest.

2 hours
total treatment time
大体时间:2 hours

total treatment time until oxygen saturation ≥96% is reached.

2 hours
subgroup analysis
大体时间:1 hour

treatment outcome analysis in patients with different baseline oxygen saturation on admission

1 hour

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2022年7月2日

初级完成 (估计的)

2027年7月15日

研究完成 (估计的)

2027年7月15日

研究注册日期

首次提交

2020年2月4日

首先提交符合 QC 标准的

2020年3月11日

首次发布 (实际的)

2020年3月13日

研究记录更新

最后更新发布 (实际的)

2026年10月5日

上次提交的符合 QC 标准的更新

2026年9月30日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅